• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼部药物递送综述。

Review of ocular drug delivery.

作者信息

Sultana Yasmin, Jain R, Aqil M, Ali Asgar

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi 110062, India.

出版信息

Curr Drug Deliv. 2006 Apr;3(2):207-17. doi: 10.2174/156720106776359186.

DOI:10.2174/156720106776359186
PMID:16611007
Abstract

Successful treatment of eye diseases requires effective concentration of drug at the eye for sufficient period of time. Conventional ocular drug delivery including eye drops, systemic administration, ophthalmic ointments, is no longer sufficient to combat ocular diseases. This article reviews the constraints with conventional ocular therapy, and explores various novel approaches, to improve the ocular bioavailability of drugs to the anterior chamber of the eye.

摘要

成功治疗眼部疾病需要药物在眼部有效浓度维持足够长的时间。包括眼药水、全身给药、眼药膏在内的传统眼部给药方式,已不足以对抗眼部疾病。本文回顾了传统眼部治疗的局限性,并探索了各种新方法,以提高药物在前房的眼部生物利用度。

相似文献

1
Review of ocular drug delivery.眼部药物递送综述。
Curr Drug Deliv. 2006 Apr;3(2):207-17. doi: 10.2174/156720106776359186.
2
Vesicular systems in ocular drug delivery: an overview.眼部给药中的囊泡系统:综述。
Int J Pharm. 2004 Jan 9;269(1):1-14. doi: 10.1016/j.ijpharm.2003.09.016.
3
Ocular preparations: the formulation approach.眼部制剂:制剂方法
Drug Dev Ind Pharm. 2002 May;28(5):473-93. doi: 10.1081/ddc-120003445.
4
Contact lenses: promising devices for ocular drug delivery.接触镜:眼部药物递送的有前途的装置。
J Ocul Pharmacol Ther. 2013 Mar;29(2):189-99. doi: 10.1089/jop.2012.0212. Epub 2012 Dec 5.
5
Contact lenses as drug-delivery systems: a promising therapeutic tool.隐形眼镜作为药物递送系统:一种有前景的治疗工具。
Arch Soc Esp Oftalmol (Engl Ed). 2020 Jan;95(1):24-33. doi: 10.1016/j.oftal.2019.07.009. Epub 2019 Aug 13.
6
Recent updates on ocular disease management with ophthalmic ointments.眼部软膏在眼病治疗管理方面的最新进展。
Ther Deliv. 2024;15(6):463-480. doi: 10.1080/20415990.2024.2346047. Epub 2024 Jun 11.
7
Topical drug delivery devices: A review.局部给药装置:综述。
Exp Eye Res. 2018 Mar;168:149-160. doi: 10.1016/j.exer.2018.01.010. Epub 2018 Jan 17.
8
Advances in ophthalmic drug delivery.眼科药物递送的进展。
Ther Deliv. 2014 Dec;5(12):1297-315. doi: 10.4155/tde.14.75.
9
Recent patents on ocular drug delivery systems.眼部药物递送系统的近期专利。
Recent Pat Drug Deliv Formul. 2008;2(1):1-8. doi: 10.2174/187221108783331410.
10
Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.眼部药物递送——靶向眼球前段和后段的新策略。
Curr Pharm Des. 2016;22(9):1135-46. doi: 10.2174/1381612822666151216145900.

引用本文的文献

1
Emerging Trends in Bilosomes as Therapeutic Drug Delivery Systems.双分子层脂质体作为治疗性药物递送系统的新趋势
Pharmaceutics. 2024 May 23;16(6):697. doi: 10.3390/pharmaceutics16060697.
2
Formulation development and evaluation of therapeutic contact lens loaded with ganciclovir.载有更昔洛韦的治疗性隐形眼镜的配方开发和评估。
Int Ophthalmol. 2023 Jul;43(7):2225-2236. doi: 10.1007/s10792-022-02618-6. Epub 2023 Jan 2.
3
Microfluidics - The State-of-the-Art Technology for Pharmaceutical Application.微流控技术——制药应用的前沿技术。
Adv Pharm Bull. 2022 Aug;12(4):700-711. doi: 10.34172/apb.2022.073. Epub 2021 Sep 29.
4
Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, characterization, and pharmacodynamic evaluation in rabbits.富透明质酸双分子层囊泡:一种通过 D-最优设计增强阿戈美拉汀眼部递药的方法:在兔体内的制剂学、特性和药效学评价。
Drug Deliv. 2022 Dec;29(1):2343-2356. doi: 10.1080/10717544.2022.2100513.
5
Ocular Fluid Mechanics and Drug Delivery: A Review of Mathematical and Computational Models.眼内流体力学与药物递送:数学和计算模型综述
Pharm Res. 2021 Dec;38(12):2003-2033. doi: 10.1007/s11095-021-03141-6. Epub 2021 Dec 22.
6
A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma.关于新型眼部给药系统的综述,重点关注青光眼
Adv Pharm Bull. 2021 May;11(3):399-413. doi: 10.34172/apb.2021.048. Epub 2020 Sep 19.
7
Recent Advances in the Excipients Used for Modified Ocular Drug Delivery.用于改良眼部药物递送的辅料的最新进展
Materials (Basel). 2021 Jul 31;14(15):4290. doi: 10.3390/ma14154290.
8
Borneol: a Promising Monoterpenoid in Enhancing Drug Delivery Across Various Physiological Barriers.龙脑:一种有前途的单萜类化合物,可增强多种生理屏障的药物传递。
AAPS PharmSciTech. 2021 Apr 28;22(4):145. doi: 10.1208/s12249-021-01999-8.
9
Biological drug therapy for ocular angiogenesis: Anti-VEGF agents and novel strategies based on nanotechnology.眼血管生成的生物药物治疗:抗 VEGF 药物和基于纳米技术的新策略。
Pharmacol Res Perspect. 2021 Apr;9(2):e00723. doi: 10.1002/prp2.723.
10
Ophthalmic delivery of hydrophilic drugs through drug-loaded oleogels.通过载药油凝胶实现亲水性药物的眼部给药。
Eur J Pharm Sci. 2021 Mar 1;158:105634. doi: 10.1016/j.ejps.2020.105634. Epub 2020 Nov 1.